{"id":32644,"date":"2023-10-17T06:06:53","date_gmt":"2023-10-17T06:06:53","guid":{"rendered":"https:\/\/www.process.st\/templates\/fda-21-cfr-part-11-compliance-checklist-2\/"},"modified":"2024-03-05T14:38:34","modified_gmt":"2024-03-05T14:38:34","slug":"fda-21-cfr-part-11-compliance-checklist-2","status":"publish","type":"post","link":"https:\/\/www.process.st\/templates\/fda-21-cfr-part-11-compliance-checklist-2\/","title":{"rendered":"FDA 21 CFR Part 11 Compliance Checklist"},"content":{"rendered":"\n<section id=\"identify-the-systems-covered-under-fda-21-cfr-part-11\"> \n <h2>Identify the systems covered under FDA 21 CFR Part 11<\/h2>\n <div class=\"text-content\">\n   In this task, you will identify the systems within your organization that are subject to FDA 21 CFR Part 11 compliance. This includes any electronic records or electronic signatures that are used in the processes regulated by the FDA. By completing this task, you will have a clear understanding of the scope of the compliance requirements and be able to move forward with the necessary steps towards compliance. \n <\/div> \n<\/section> \n<section id=\"define-regulatory-requirements\"> \n <h2>Define regulatory requirements<\/h2>\n <div class=\"text-content\">\n   In this task, you will define the regulatory requirements for FDA 21 CFR Part 11 compliance. This includes understanding the specific regulations and guidelines set forth by the FDA and how they apply to your organization's systems and processes. By defining these requirements, you will ensure that your organization is meeting the necessary standards for compliance. \n <\/div> \n<\/section> \n<section id=\"define-organizational-policies-and-procedures-for-fda-21-cfr-part-11\"> \n <h2>Define organizational policies and procedures for FDA 21 CFR Part 11<\/h2>\n <div class=\"text-content\">\n   In this task, you will define the organizational policies and procedures for FDA 21 CFR Part 11 compliance. This includes establishing a set of rules and guidelines that outline how your organization will achieve and maintain compliance with the FDA regulations. By creating these policies and procedures, you will provide a framework for your organization to follow in order to meet the compliance requirements. \n <\/div> \n<\/section> \n<section id=\"identify-system-functionality-data-criticality-and-data-sensitivity\"> \n <h2>Identify system functionality, data criticality, and data sensitivity<\/h2>\n <div class=\"text-content\">\n   In this task, you will identify the functionality of the systems covered under FDA 21 CFR Part 11, as well as the criticality and sensitivity of the data stored and processed by these systems. By understanding the functionality, criticality, and sensitivity of the systems and data, you will be able to assess the level of control and security measures required for compliance. \n <\/div> \n<\/section> \n<section id=\"define-security-measures-for-the-systems\"> \n <h2>Define security measures for the systems<\/h2>\n <div class=\"text-content\">\n   In this task, you will define the security measures that need to be implemented for the systems covered under FDA 21 CFR Part 11. This includes access control, data encryption, audit trails, and other security measures to ensure the integrity, confidentiality, and availability of the electronic records and signatures. By defining these security measures, you will strengthen the overall security posture of the systems and meet the compliance requirements. \n <\/div> \n<\/section> \n<section id=\"build-a-comprehensive-validation-plan\"> \n <h2>Build a comprehensive validation plan<\/h2>\n <div class=\"text-content\">\n   In this task, you will build a comprehensive validation plan for the systems covered under FDA 21 CFR Part 11. This plan will outline the validation activities, deliverables, and timelines required to demonstrate that the systems meet the compliance requirements. By creating a validation plan, you will ensure that the systems are thoroughly tested and validated before being put into production. \n <\/div> \n<\/section> \n<section id=\"create-and-execute-system-validation-scripts\"> \n <h2>Create and execute system validation scripts<\/h2>\n <div class=\"text-content\">\n   In this task, you will create and execute system validation scripts for the systems covered under FDA 21 CFR Part 11. These scripts will test the functionality, security, and data integrity of the systems to ensure compliance with the FDA regulations. By executing these validation scripts, you will gather evidence to support the compliance of the systems. \n <\/div> \n<\/section> \n<section id=\"approval-validation-plan-approval-by-quality-assurance\"> \n <h2>Approval: Validation Plan Approval by Quality Assurance<\/h2>\n <div class=\"approval-content\"> \n  <div class=\"header\"> \n   <div class=\"list-title\">\n    Will be submitted for approval:\n   <\/div> \n  <\/div> \n  <div class=\"approval-rule-subject-tasks-list\"> \n   <ul class=\"list\"> \n    <li> \n     <div class=\"approval-rule-subject-tasks-list-item\"> \n      <div class=\"item\"> \n       <div class=\"container\"> <span class=\"title\">Build a comprehensive validation plan<\/span> \n        <div class=\"body\">\n         Will be submitted\n        <\/div> \n       <\/div> \n      <\/div> \n     <\/div> <\/li> \n   <\/ul> \n  <\/div> \n <\/div> \n<\/section> \n<section id=\"document-all-validation-protocols-and-results\"> \n <h2>Document all validation protocols and results<\/h2>\n <div class=\"text-content\">\n   In this task, you will document all validation protocols and results for the systems covered under FDA 21 CFR Part 11. This includes the protocols used during the validation process, as well as the results and any deviations or issues encountered. By documenting the validation protocols and results, you will have a clear record of the validation activities and be able to demonstrate compliance with the FDA regulations. \n <\/div> \n<\/section> \n<section id=\"train-system-users-to-understand-and-comply-with-fda-21-cfr-part-11\"> \n <h2>Train system users to understand and comply with FDA 21 CFR Part 11<\/h2>\n <div class=\"text-content\">\n   In this task, you will train system users to understand and comply with FDA 21 CFR Part 11. This includes providing training on the requirements, policies, and procedures for compliance, as well as any specific system functionalities or security measures. By training system users, you will ensure that they have the knowledge and skills necessary to use the systems in a compliant manner. \n <\/div> \n<\/section> \n<section id=\"regulate-the-process-of-change-management-in-systems\"> \n <h2>Regulate the process of Change management in systems<\/h2>\n <div class=\"text-content\">\n   In this task, you will regulate the process of change management in the systems covered under FDA 21 CFR Part 11. This includes establishing a formal process for requesting, reviewing, approving, and implementing changes to the systems. By regulating the change management process, you will ensure that any changes made to the systems do not impact their compliance with the FDA regulations. \n <\/div> \n<\/section> \n<section id=\"audit-trail-review-for-system\"> \n <h2>Audit trail review for system<\/h2>\n <div class=\"text-content\">\n   In this task, you will perform an audit trail review for the systems covered under FDA 21 CFR Part 11. This includes examining the audit trails generated by the systems to verify the integrity and traceability of the electronic records and signatures. By performing this review, you will identify any discrepancies or anomalies in the audit trails and take appropriate actions to address them. \n <\/div> \n<\/section> \n<section id=\"approval-audit-result-review-by-compliance-manager\"> \n <h2>Approval: Audit Result Review by Compliance Manager<\/h2>\n <div class=\"approval-content\"> \n  <div class=\"header\"> \n   <div class=\"list-title\">\n    Will be submitted for approval:\n   <\/div> \n  <\/div> \n  <div class=\"approval-rule-subject-tasks-list\"> \n   <ul class=\"list\"> \n    <li> \n     <div class=\"approval-rule-subject-tasks-list-item\"> \n      <div class=\"item\"> \n       <div class=\"container\"> <span class=\"title\">Audit trail review for system<\/span> \n        <div class=\"body\">\n         Will be submitted\n        <\/div> \n       <\/div> \n      <\/div> \n     <\/div> <\/li> \n   <\/ul> \n  <\/div> \n <\/div> \n<\/section> \n<section id=\"maintain-a-regular-system-back-up-and-disaster-recovery-plan\"> \n <h2>Maintain a regular system back up and disaster recovery plan<\/h2>\n <div class=\"text-content\">\n   In this task, you will maintain a regular system backup and disaster recovery plan for the systems covered under FDA 21 CFR Part 11. This includes implementing regular backup processes to ensure the availability and integrity of the electronic records and signatures, as well as a plan for recovering the systems in case of a disaster. By maintaining these backup and recovery measures, you will minimize the risk of data loss and ensure business continuity. \n <\/div> \n<\/section> \n<section id=\"identify-and-classify-system-anomalies-and-issues\"> \n <h2>Identify and classify system anomalies and issues<\/h2>\n <div class=\"text-content\">\n   In this task, you will identify and classify system anomalies and issues for the systems covered under FDA 21 CFR Part 11. This includes documenting any deviations, errors, or malfunctions encountered during the operation of the systems. By identifying and classifying these anomalies and issues, you will be able to address them appropriately and ensure the continued compliance of the systems. \n <\/div> \n<\/section> \n<section id=\"perform-a-risk-analysis-for-system-anomalies-and-issues\"> \n <h2>Perform a risk analysis for system anomalies and issues<\/h2>\n <div class=\"text-content\">\n   In this task, you will perform a risk analysis for system anomalies and issues identified in the systems covered under FDA 21 CFR Part 11. This includes assessing the potential impact and likelihood of these anomalies and issues on the compliance and functionality of the systems. By performing this risk analysis, you will be able to prioritize and address the most critical risks to ensure the continued compliance of the systems. \n <\/div> \n<\/section> \n<section id=\"develop-a-resolution-plan-for-system-anomalies-and-issues\"> \n <h2>Develop a resolution plan for system anomalies and issues<\/h2>\n <div class=\"text-content\">\n   In this task, you will develop a resolution plan for system anomalies and issues identified in the systems covered under FDA 21 CFR Part 11. This plan will outline the steps and actions required to address and resolve the identified anomalies and issues. By developing a resolution plan, you will ensure that the necessary actions are taken to maintain the compliance and functionality of the systems. \n <\/div> \n<\/section> \n<section id=\"approval-anomaly-resolution-plan-approval-by-quality-assurance\"> \n <h2>Approval: Anomaly Resolution Plan Approval by Quality Assurance<\/h2>\n <div class=\"approval-content\"> \n  <div class=\"header\"> \n   <div class=\"list-title\">\n    Will be submitted for approval:\n   <\/div> \n  <\/div> \n  <div class=\"approval-rule-subject-tasks-list\"> \n   <ul class=\"list\"> \n    <li> \n     <div class=\"approval-rule-subject-tasks-list-item\"> \n      <div class=\"item\"> \n       <div class=\"container\"> <span class=\"title\">Identify and classify system anomalies and issues<\/span> \n        <div class=\"body\">\n         Will be submitted\n        <\/div> \n       <\/div> \n      <\/div> \n     <\/div> <\/li>\n    <li> \n     <div class=\"approval-rule-subject-tasks-list-item\"> \n      <div class=\"item\"> \n       <div class=\"container\"> <span class=\"title\">Perform a risk analysis for system anomalies and issues<\/span> \n        <div class=\"body\">\n         Will be submitted\n        <\/div> \n       <\/div> \n      <\/div> \n     <\/div> <\/li>\n    <li> \n     <div class=\"approval-rule-subject-tasks-list-item\"> \n      <div class=\"item\"> \n       <div class=\"container\"> <span class=\"title\">Develop a resolution plan for system anomalies and issues<\/span> \n        <div class=\"body\">\n         Will be submitted\n        <\/div> \n       <\/div> \n      <\/div> \n     <\/div> <\/li> \n   <\/ul> \n  <\/div> \n <\/div> \n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Identify the systems covered under FDA 21 CFR Part 11 In this task, you will identify the systems within your organization that are subject to FDA 21 CFR Part 11 compliance. This includes any electronic records or electronic signatures that are used in the processes regulated by the FDA. By completing this task, you will [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"ep_exclude_from_search":false,"cover_icon_emoji":"\ud83d\udcdd","cover_icon_url":"","tasks_count":"18","template_description":"","template_id":"v7FgdImSH3mlspmgI5FMxg","task_0":"Identify the systems covered under FDA 21 CFR Part 11","task_slug_0":"identify-the-systems-covered-under-fda-21-cfr-part-11","task_1":"Define regulatory requirements","task_slug_1":"define-regulatory-requirements","task_2":"Define organizational policies and procedures for FDA 21 CFR Part 11","task_slug_2":"define-organizational-policies-and-procedures-for-fda-21-cfr-part-11","task_3":"Identify system functionality, data criticality, and data sensitivity","task_slug_3":"identify-system-functionality-data-criticality-and-data-sensitivity","task_4":"Define security measures for the systems","task_slug_4":"define-security-measures-for-the-systems","task_5":"Build a comprehensive validation plan","task_slug_5":"build-a-comprehensive-validation-plan","task_6":"Create and execute system validation scripts","task_slug_6":"create-and-execute-system-validation-scripts","task_7":"Approval: Validation Plan Approval by Quality Assurance","task_slug_7":"approval-validation-plan-approval-by-quality-assurance","task_8":"Document all validation protocols and results","task_slug_8":"document-all-validation-protocols-and-results","task_9":"Train system users to understand and comply with FDA 21 CFR Part 11","task_slug_9":"train-system-users-to-understand-and-comply-with-fda-21-cfr-part-11","task_10":"Regulate the process of Change management in systems","task_slug_10":"regulate-the-process-of-change-management-in-systems","task_11":"Audit trail review for system","task_slug_11":"audit-trail-review-for-system","task_12":"Approval: Audit Result Review by Compliance Manager","task_slug_12":"approval-audit-result-review-by-compliance-manager","task_13":"Maintain a regular system back up and disaster recovery plan","task_slug_13":"maintain-a-regular-system-back-up-and-disaster-recovery-plan","task_14":"Identify and classify system anomalies and issues","task_slug_14":"identify-and-classify-system-anomalies-and-issues","task_15":"Perform a risk analysis for system anomalies and issues","task_slug_15":"perform-a-risk-analysis-for-system-anomalies-and-issues","task_16":"Develop a resolution plan for system anomalies and issues","task_slug_16":"develop-a-resolution-plan-for-system-anomalies-and-issues","task_17":"Approval: Anomaly Resolution Plan Approval by Quality Assurance","task_slug_17":"approval-anomaly-resolution-plan-approval-by-quality-assurance","task_18":"","task_slug_18":"","task_19":"","task_slug_19":"","task_20":"","task_slug_20":"","task_21":"","task_slug_21":"","task_22":"","task_slug_22":"","task_23":"","task_slug_23":"","task_24":"","task_slug_24":"","task_25":"","task_slug_25":"","task_26":"","task_slug_26":"","task_27":"","task_slug_27":"","task_28":"","task_slug_28":"","task_29":"","task_slug_29":"","task_30":"","task_slug_30":"","task_31":"","task_slug_31":"","task_32":"","task_slug_32":"","task_33":"","task_slug_33":"","task_34":"","task_slug_34":"","task_35":"","task_slug_35":"","task_36":"","task_slug_36":"","task_37":"","task_slug_37":"","task_38":"","task_slug_38":"","task_39":"","task_slug_39":"","task_40":"","task_slug_40":"","task_41":"","task_slug_41":"","task_42":"","task_slug_42":"","task_43":"","task_slug_43":"","task_44":"","task_slug_44":"","task_45":"","task_slug_45":"","task_46":"","task_slug_46":"","task_47":"","task_slug_47":"","task_48":"","task_slug_48":"","task_49":"","task_slug_49":"","task_50":"","task_slug_50":"","task_51":"","task_slug_51":"","task_52":"","task_slug_52":"","task_53":"","task_slug_53":"","task_54":"","task_slug_54":"","task_55":"","task_slug_55":"","task_56":"","task_slug_56":"","task_57":"","task_slug_57":"","task_58":"","task_slug_58":"","task_59":"","task_slug_59":"","task_60":"","task_slug_60":"","task_61":"","task_slug_61":"","task_62":"","task_slug_62":"","task_63":"","task_slug_63":"","task_64":"","task_slug_64":"","task_65":"","task_slug_65":"","task_66":"","task_slug_66":"","task_67":"","task_slug_67":"","task_68":"","task_slug_68":"","task_69":"","task_slug_69":"","task_70":"","task_slug_70":"","task_71":"","task_slug_71":"","task_72":"","task_slug_72":"","task_73":"","task_slug_73":"","task_74":"","task_slug_74":"","task_75":"","task_slug_75":"","task_76":"","task_slug_76":"","task_77":"","task_slug_77":"","task_78":"","task_slug_78":"","task_79":"","task_slug_79":"","task_80":"","task_slug_80":"","task_81":"","task_slug_81":"","task_82":"","task_slug_82":"","task_83":"","task_slug_83":"","task_84":"","task_slug_84":"","task_85":"","task_slug_85":"","task_86":"","task_slug_86":"","task_87":"","task_slug_87":"","task_88":"","task_slug_88":"","task_89":"","task_slug_89":"","task_90":"","task_slug_90":"","task_91":"","task_slug_91":"","task_92":"","task_slug_92":"","task_93":"","task_slug_93":"","task_94":"","task_slug_94":"","task_95":"","task_slug_95":"","task_96":"","task_slug_96":"","task_97":"","task_slug_97":"","task_98":"","task_slug_98":"","task_99":"","task_slug_99":"","footnotes":""},"categories":[29,113],"tags":[],"class_list":["post-32644","post","type-post","status-publish","format-standard","hentry","category-healthcare","category-medical"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.process.st\/templates\/wp-json\/wp\/v2\/posts\/32644","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.process.st\/templates\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.process.st\/templates\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.process.st\/templates\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.process.st\/templates\/wp-json\/wp\/v2\/comments?post=32644"}],"version-history":[{"count":0,"href":"https:\/\/www.process.st\/templates\/wp-json\/wp\/v2\/posts\/32644\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.process.st\/templates\/wp-json\/wp\/v2\/media?parent=32644"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.process.st\/templates\/wp-json\/wp\/v2\/categories?post=32644"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.process.st\/templates\/wp-json\/wp\/v2\/tags?post=32644"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}